Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 37 of 115 for:    Rheumatoid Arthritis | "Connective Tissue Disease" | "Abatacept"

TOward the Lowest Effective DOse of Abatacept or Tocilizumab (TOLEDO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01557374
Recruitment Status : Active, not recruiting
First Posted : March 19, 2012
Last Update Posted : February 5, 2019
Sponsor:
Collaborator:
Ministry of Health, France
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021